Skip to content
HowShorted

ANAVEX LIFE SCIENCES CORP. short interest in 2020

In 2020, ANAVEX LIFE SCIENCES CORP.'s disclosed short interest ran from 11.62% of shares outstanding on 15 Jan 2020 to 8.39% on 31 Dec 2020, a change of -3.23 percentage points. The year's high was 13.67% on 13 Mar 2020 and its low 8.39% on 31 Dec 2020, averaging 11.90% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 16.37 days on 15 Sep 2020. Full history: ANAVEX LIFE SCIENCES CORP..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for ANAVEX LIFE SCIENCES CORP. in 2020

2020 in figures

Start of year
11.62% (15 Jan 2020)
End of year
8.39% (31 Dec 2020)
Change
-3.23 pp
High
13.67% (13 Mar 2020)
Low
8.39% (31 Dec 2020)
Average
11.90%
Highest days to cover
16.37 (15 Sep 2020)
SEC filings marked
5

Every report in 2020

ANAVEX LIFE SCIENCES CORP. short interest in 2020
SettlementShort interestDays to coverFilings since previous
15 Jan 202011.62%7.88
31 Jan 202011.96%11.50
14 Feb 202012.36%3.7910-Q filed
28 Feb 202013.10%3.80
13 Mar 202013.67%6.94
31 Mar 202012.85%6.62
15 Apr 202013.36%11.93
30 Apr 202013.04%15.04
15 May 202012.46%12.7510-Q filed
29 May 202011.04%11.24
15 Jun 202010.36%10.68
30 Jun 202010.90%5.10
15 Jul 202011.76%11.58
31 Jul 202010.31%15.39
14 Aug 202012.37%8.1710-Q filed
31 Aug 202011.96%16.22
15 Sep 202012.74%16.37
30 Sep 202012.20%9.86
15 Oct 202011.76%14.62
30 Oct 202010.95%5.10
13 Nov 202012.84%3.71
30 Nov 202012.34%10.49
15 Dec 202011.17%8.69
31 Dec 20208.39%4.3610-K filed, results (8-K)

See also: ANAVEX LIFE SCIENCES CORP.'s full history · most shorted US stocks of 2020 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.